DUBLIN--(BUSINESS WIRE)--The "Global Positive Airway Pressure Devices Industry" report has been added to ResearchAndMarkets.com's offering.
The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030. The market is expected to grow at a CAGR of 6.03% during the forecast period from 2021 to 2030.
A positive airway pressure delivery system is a prescription non-invasive ventilatory device that delivers expiratory positive airway pressure for patients suffering from obstructive sleep apnea. The system also provides positive airway pressure during incipient apnea. The system may include a dedicated flow generator and a patient interface.
Sleep apnea is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing the soft tissue at the back of the throat to collapse and block the upper airway. Obstructive sleep apnea is also one of the independent risk factors for stroke, cardiovascular diseases, and systemic hypertension, among other clinical consequences. Globally, sleep apnea impacts more than 936 million individuals worldwide. The American Academy of Sleep Medicine (AASM) recommends that continuous positive airway pressure (CPAP) devices be considered first-line treatment for moderate and severe OSA.
Despite the recommendations, CPAP devices and PAP devices in general frequently encounter challenges in terms of adherence. There are a number of factors that contribute to the low adherence rates for PAP devices. These factors primarily include claustrophobia, discomfort, and high cost. Several studies have been conducted to identify the reason behind low adherence rates despite several changes in the device and mask dynamics.
Key Questions Answered in the Global Positive Airway Pressure Devices Market Report:
- How has COVID-19 impacted the adoption of PAP devices in the market?
- What are the key regulations which influence the adoption of PAP devices in the market?
- What are some of the key companies in the global and regional PAP market?
- What are some of the key factors influencing the growth in adopting PAP devices across the globe?
- What are some of the growth opportunities which market players can capitalize on?
- What is the PAP device adoption rate for patients diagnosed with sleep apnea?
- What are the compliance and discontinuation rates for PAP therapy across regions?
- What are the fastest-growing countries in terms of PAP devices adoption?
- Which are the key diseases driving the adoption of PAP devices across the world?
- What are the key strategies being adopted by market players in the global positive airway pressure devices market?
- Who are the most common end-users of PAP devices, and how are the end-use segment expected to grow in the future?
Impact of COVID-19 on the Positive Airway Pressure Devices Industry
The impact of COVID-19 varies depending on the region, country, the extent of lockdowns, and the perception of the local population.
The market witnessed a temporary boost in demand when CPAP devices were approved for emergency use by regulatory bodies to bridge the gap between demand for and supply of ventilators.
Key areas of the supply chain were impacted during the initial days of the pandemic, which comprised coinciding lockdowns in several countries leading to a restriction in global logistics. The resulting strain led to reduced stock in warehouses and a hike in logistics costs locally.
Market Dynamics
Growth Drivers
- Rising Number of Startups Driving Innovation
- Increasing Prevalence of Obstructive Sleep Apnea
- Growing Prevalence of Respiratory Diseases among the Geriatric Population
- Growing Prevalence of Chronic Respiratory Diseases across the Globe
Challenges
- High Upfront Cost of the Devices
- Side-Effects Associated with Long-Term Usage
Opportunities
- Development of Smart PAP Devices
- Deployment of 3D Scanning to Offer Customized PAP Masks
- Development of Accessory-Free PAP Devices
Companies Mentioned
- 3B Medical, Inc
- Apex Medical Corporation
- BMC Medical Co. Ltd.
- Breas Medical AB
- Compumedics Limited
- Drive DeVilbiss Healthcare
- Elmaslar Group
- Fisher & Paykel Healthcare Corporation Limited
- Hebei Topson Medical Technology Co., Ltd.
- Kare Medical and Analytical Devices Ltd. Co.
- Koninklijke Philips N.V.
- Lowenstein Medical Technology GmbH + Co. KG.
- Narang Medical Limited
- ResMed Inc.
- Somnetics International, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/4ls4tx
